Tubastatin A alone reduced the HDAC6 levels in autophagosomes of GBM cells, whereas the combination treatment promotes the association of HDAC6 to VCP/p97, resulting in defects in the clearance of misfolded proteins through the HDAC6-dependent autophagic pathway while promoting UPS [319]. This evidence concerns the gene HDAC6 and glioblastoma.